Kenneth B. Lee, Jr.

Interim Chief Executive Officer, Chairman of the Board
Ken Lee

Kenneth B. Lee, Jr. was named Interim Chief Executive Officer on April 30, 2021. A former Chief Financial Officer for the CEO Roundtable, he also serves as Chairman of the CEO Roundtable on Cancer's Board of Directors.

Lee has more than 35 years of experience counseling management teams and is General Partner of Hatteras Venture Partners, LLC. In 2018, he received the CEORT’s prestigious Dr. Charles A. Sanders Life Sciences Award for his contributions to this organization. 

As the former head of the US Life Sciences Practice and co-head of International Life Sciences for Ernst & Young, Lee established a career over 29 years advising biotechnology and pharmaceutical companies throughout the world.

He got his start in biotech as part of the first audit team of Genentech in 1976. As co-founder and manager of the firm’s national life sciences practice from his location in the San Francisco Bay Area, he advised numerous high profile life science companies with their initial public offerings, mergers and acquisitions, and strategic financings. 

He graduated with a BA from Lenoir-Rhyne College and has an MBA from the University of North Carolina at Chapel Hill. A nationally recognized expert on financial matters, he serves on the boards of Biocryst and Eyenovia as well as the Board of the North Carolina Medical Foundation and on the Board of Visitors of the Lineberger Cancer Center at the University of North Carolina.

     

      Contact Kenneth B. Lee, Jr.

      CAPTCHA
      This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.